Hospitalization Costs in Schizophrenia: Long-acting Injectable (LAI) versus Oral Antipsychotic Use
Download Publication
Inpatient Hospitalizations and Costs in Patients with Schizophrenia Initiating LAIs
Download Publication
Treatments and Outcomes of Idiopathic Pulmonary Fibrosis in a Medicare Population Prior to Approval of Anti-fibrotic Therapies
Download Publication
Testing Leading to the Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Patients
Download Publication
Testing Leading to the Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Patients
Download Publication
Real-world evidence on the use of three recently approved long acting injectable antipsychotics in the United States: statistical and cost analysis in patients with schizophrenia
Download Publication
Total and excess costs associated with bipolar I disorder in the United States in 2015
Download Publication